Document is current

Any future updates will be listed below

Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression

Crossref DOI link: https://doi.org/10.1007/s00280-015-2936-z

Published Online: 2015-12-17

Published Print: 2016-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark